Results 141 to 150 of about 29,180 (194)
Temperature and drug treatments in mevalonate kinase deficiency: an ex vivo study. [PDF]
Tricarico PM +6 more
europepmc +1 more source
Metabolic-Immune Crosstalk in Pediatric Rheumatology: From Pathogenesis to Precision Therapy. [PDF]
Shashaani N +4 more
europepmc +1 more source
Molecular and cellular consequences of mevalonate kinase deficiency.
Mevalonate kinase deficiency (MKD) is an autosomal recessive metabolic disorder associated with recurrent autoinflammatory episodes. The disorder is caused by bi-allelic loss-of-function variants in the MVK gene, which encodes mevalonate kinase (MK), an ...
Frouwkje A. Politiek +4 more
semanticscholar +3 more sources
Mevalonate Kinase Deficiency: A Cause of Severe Very-Early-Onset Inflammatory Bowel Disease.
Mevalonate kinase deficiency should be considered in patients with severe very-early-onset inflammatory bowel disease (IBD), especially in patients with a history of recurrent or chronic fever, peritoneal adhesions, and atypical IBD pathology.
B. Bader-Meunier +15 more
semanticscholar +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
2019
Mevalonate kinase deficiency (MKD) is a rare autosomal recessive autoinflammatory disease caused by mutations in the mevalonate kinase (MVK) gene. It is characterized by recurrent attacks of fever mostly associated with cervical lymphadenopathy, cutaneous, digestive, and musculoskeletal manifestations.
Joost Frenkel +2 more
exaly +3 more sources
Mevalonate kinase deficiency (MKD) is a rare autosomal recessive autoinflammatory disease caused by mutations in the mevalonate kinase (MVK) gene. It is characterized by recurrent attacks of fever mostly associated with cervical lymphadenopathy, cutaneous, digestive, and musculoskeletal manifestations.
Joost Frenkel +2 more
exaly +3 more sources
Mevalonate kinase deficiency nomenclature
Rheumatology International, 2013In the letter of Celsi et al. [1], the authors suggest dropping the names of hyper-IgD syndrome (HIDS) and mevalonate kinase deficiency (MKD) for this hereditary syndrome. They base their conclusion upon the fact that there is no correlation between serum IgD concentration and disease severity, that not all HIDS patients show elevated IgD, and that ...
Stoffels, M. +2 more
openaire +3 more sources
Uveitis, glaucoma, and cataract with mevalonate kinase deficiency
Journal of American Association for Pediatric Ophthalmology and Strabismus, 2022We report 7 years of follow-up data on ocular findings in a 2-month-old boy who presented with early-onset bilateral granulomatous panuveitis with subsequent development of secondary glaucoma and total cataract, along with multisystem involvement. He was diagnosed with mevalonate kinase deficiency (MKD), with a homozygous missense variant in exon-6 of ...
Nidhi, Agarwal, Mihir, Kothari
openaire +2 more sources
Mevalonate kinase deficiency (MKD) is a rare autosomal recessive autoinflammatory disease caused by biallelic mutations in the MVK gene. The phenotypic spectrum is variable and ranges from periodic fever syndrome (PFS) to mevalonic aciduria (MA), with ...
M. Céleste +3 more
semanticscholar +2 more sources
Mutational spectrum and genotype–phenotype correlations in mevalonate kinase deficiency
Mevalonate kinase deficiency (MKD) is an autosomal recessive autoinflammatory disorder caused by mutations in the MVK gene resulting in deficient activity of mevalonate kinase (MK).
Janet Koster, Hans R Waterham
exaly +2 more sources

